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1. Introduction
Breast cancer is the most frequently diagnosed cancer in women aged 40 to 65 years, with more
than 464,000 new cases (13.5% of all cancer cases) per year in Europe [1,2]. Approximately 5%
of breast cancer patients have advanced (metastatic) disease at diagnosis. Despite important
progress in adjuvant and neoadjuvant therapies, up to 90% of cancer deaths are due to
complications arising from metastatic dissemination of the disease [3,4].For patients with
established metastatic disease, therapy is usually for palliation.
Metastasis is a complex process, entailing tumor cells acquiring a set of features that allow
them to develop new foci of the disease. Its exact mechanism remains unclear. Metastasis has
been described as the migration of tumor cells from the primary tumor, followed by intrava‐
sation, survival, extravasation of the circulatory system, and progressive colonization of a
distant site [5-7]. In a second definition, tumor cell genomic instability occurs that enables
invasion and distant organ colonization [8].In another definition, metastasis is described in
terms of seed and soil [9]. Tumor cells (seeds) spread widely through the body, but grow only
in supportive locations (congenial soil). Thus the various microenvironments (soils) of
metastases contribute to the observed heterogeneity [9].
The most common sites of breast cancer metastases are the bones, brain, adrenal glands and
other parts of the body [10,11]. Metastatic bone disease alters the mechanical properties of the
involved bones, produces painful osteolysis, microfractures, and eventually complete frac‐
tures.The extent to which metastases are site specific and the transformation of healthy cells
into cancer cells also remain poorly understood. A hallmark of breast cancer metastasis is the
redundancy of pathways that mediate the process or its component steps, and theabound of
promoting genes [3]. Some pathways contribute to bone metastasis, while other pathways have
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and eproduction in any medium, provided the original work is properly cited.
been reported to mediate lung and liver metastasis. Advanced next-generation sequencing
techniques have also been used to interrogate whole cancer genomes at the single-nucleotide
level and have distinguished between mutations in breast cancer metastases [12,13]. However,
one metastasis may be distinct from another within the same patient accurate prediction of the
molecular profile of metastatic disease by profiling the primary tumor is not feasible. In this
setting, novel detection techniques are necessary [14].
Fourier transform infrared spectroscopy is a physicochemical, non-destructive, sensitive and
reproducible method which provides important information about changes in the molecular
structure of the bone due to the disease [15-29]. The advantage of the method is that it needs
small amounts of the sample (only few micrograms) and we could study the sample without
any preparation, such as coloring or demineralization as it is done in histopathology, since the
spectra are based on individual chemical characteristics of the bone. Another important
advantage of the infrared spectroscopy is that the method does not require any preparation of
the sample, such as coloring or decalcification, as in methods like histopathology, where the
samples are decalcified and labeled with color and are analyzed only the changes in the organic
phase of the tissues.In infrared spectroscopy, the spectrum is the sum of all the frequencies of
the components present and provides information on all components simultaneously [15-21].
Here within it is presented the influence of cancer on the molecular structure of the constituents
of the bone (Hydroxyapatite, Collagen and Protein) and the characterization of the spectral
differences between healthy and cancerous bones, in order to have a better insight of the
process of the disease.
2. Materials and methods
2.1. Sample preparation
Although  breast  cancer  metastases  to  skeleton  bones  are  frequent  sites  of  first  distant
relapse,however the bone samples are not easy to be obtained. Six bone sections from breast
metastatic cancer patients (39 and 65 years), who suffered from breast cancer and under‐
went  a  reconstruction with an osteoarticular  allograft,  were  used for  the  present  study.
Small  amount  of  fresh  bones  (cancellous  or/compact),  were  immersed  successively  in
hydrogen peroxide  solution (H2O2)  and in  acetone,  according to  a  modification method
[15-17, 20,30]. Hydrogen peroxide and acetone processing is known to reduce the fat tissue




The conformational and molecular changes of healthy and cancerous bones were recorded
using a Nicolet 6700 thermoscientific Transform Infrared (FT-IR) spectrometer, which was
connected to an attenuated total reflection (ATR) accessory. This technique is convenient in
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this case for the cancerous bones since it is almost impossible to powderize these tissues.More‐
over, impregnated with PMMA bone appears less suited, because when remove the plastic
there is dangerous to loose important components.
Each absorption spectrum of the samples was consisted of 120 co-added spectra at a resolution
of 4 cm−1 and all spectra were obtained in the same way in absorption mode in the spectral
region 4000-400 cm-1.The interpretation of the spectra was done by analyzing the spectra and
comparing the spectral data between cancerous and healthy tissues in order to follow and
show the characteristic pattern of the disease. Data analysis was performed with the OMNIC
7.3 software.
2.2.2. Scanning electron microscope
Scanning electron microscopy (SEM) is also a non-destructive method, which allows the
investigation of the surfaces of cancerous bone tissues, without any decalcification, coloring
or coating. Under these conditions, there is not any change in chemical bonds between mineral
and organic phase of the sample.
The distribution of the morphology of samples and bone mineral content were obtained using
the (SEM) equipped with a microanalyzer probe EDX (Electron Dispersive X-rays analysis)
from Fei Co, Eindhoven, The Netherlands
2.2.3. X-Ray diffraction
X-Ray diffraction, XRD, was used to identify the crystal structure of hydroxyl apatite and the
presence of other calcium phosphate salts, which were produced with the progress of the
cancer metastasis and development.
Powdered bone diffraction patterns were recorded using a Siemens D-500 X-Ray diffractom‐
eter based on an automatic adjustment and analysis system. The diffraction interval was of 2θ
5-80o and scan rate of 0.030o/s.
3. Results and discussion
3.1. Infrared spectroscopic analysis
In the treatment of breast cancer, the occurrence and growth of distant metastases is the
major cause of morbidity and mortality. Long distant metastasis of breast cancer to bones
induces micro-fractures changing the patients’  quality of  life.  To understand the mecha‐
nism of the cancer cell dispersive and damaging effects which are induced to bone structure
is of  high interest  in order to study the disease.  Figure 1 shows the FT-IR spectra of a)
healthy radius bones and b) of cancerous bones from a woman (59 years old) with a primary
breast cancer.
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Figure 1. FT-IR spectra of a) healthy bone and b) cancerous bone from a 59 years woman with metastatic bone cancer
from breast cancer the original site
Comparison of the two spectra showed considerable changes in the whole spectral range of
3600-400 cm-1. The intensity of the shoulder band near 3550 cm-1 for healthy bones was reduced
or disappeared in all cancerous bones. Deconvolution of this band showed that it was double
with maxima at 3515 cm-1 and 3400 cm-1, which are dominated by the absorption of stretching
vibration of vOH functional groups of water and hydroxyapatite, respectively [15-17, 19,20].
The intensities of these bands are sensitive at the demineralization of the bones due to disease
cancer and they can show the progress of osteolysis. The broad band in the region 3300-3000
cm-1is made up from the two bands at 3209 cm-1 and 3187cm-1, assigned to NH vibrations
[15-30]. In cancerous bone spectra the band at 3209cm-1 shifted to higher wavenumbers at 3277
cm-1 and the 3187 cm-1 was reduced in intensity, but it was not shifted. It seems that in cancerous
bones the binding of proteins changed in structure and they did not give neither inter-nor
intra-molecular hydrogen bonding of the NH hydrogen bonding leading to the result that
decalcification takes place and finally the disease changes the secondary molecular structure
of the proteins.
The absorption bands of  the  symmetric  and asymmetric  stretching vibrations  of  methyl
(vasCH3  and  vsCH3)  groups  were  found  at  2965  cm-1  and  2880  cm-1  and  of  methylene
(vasCH2and vsCH2) were near 2926 cm-1 and 2854 cm-1, respectively [15-31]. These bands did
not shift but their intensities increased for cancerous bones. These changes indicated that
the environment of lipids, phospholipids and proteins has changed and that the permeabil‐
ity and fluidity of the membranes have increased, due to the damage induced by the disease
and demineralization [15-30].
Interesting was the appearance of a new band in the spectra of cancerous bones at about 1745
cm-1, which was assigned to vC=O carbonyl stretching vibration of ester carbonyl groups (RO-
C=O) and was attributed to formation of aldehydes [31,32]. It is known that aldehydes are
recognized as native “cancer markers” [33]. This carbonyl band was also proposed to charac‐
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terize the apoptotic cells [34]. This particular band indicates that lipid peroxidation was one
of the pathways during the process of metastasis of bone cancer and could be used as “marker
band” for the progression of the disease.This fact leads also to the hypothesis that the immune-
like systemis a contribution to the development of metastasis, in agreement with literature
data [34].
Considerable changes were also observed in the region 1700-1500 cm-1. This region is known
to be characteristic of proteins and is sensitive in order to evaluate the secondary structure of
proteins and to distinguish that collagen exists as α-helix [15-17,30-32]. A shift to lower
frequencies of the absorption band of Amide I of proteins from about 1650 cm-1 in healthy
bones to 1630 cm-1 in cancerous bones was observed. This shift to lower frequencies suggests
that the proteins changed their secondary structure from α-helix to random coil due to cancer
processing. These results were confirmed also from SEM analysis.
Figure 2 shows the morphology of the cancerous bone. One can see that the bone is rich in
fibrils, concerning the damage of collagenous and non-collagenous proteins, as well as the
demineralization of the bone. The proteins changed their native structure as shown from the
arrows on the points of damaged proteins (Fig. 2C). Image J analysis gives the relative intensity
of the pixels which correspond to electron density of the proteins (Fig. D & E). The curves show
the analyzed regions at the misfolding points.
Figure 2. SEM morphology of metastatic breast cancerous bone (scale 500 μm, Mag. 100x). B Selected region rich in
proteins, C: Higher magnitude 800x (scale 50 μm), which shows the misfolding of proteins. D & E ImageJ analysis of
the folding regions
The Amide II band at 1555 cm-1, which is consisted from δNH in-plane and vCN stretching
vibrations, is very sensitive to environmental changes. It was found that the intensity of this
band decreases and in almost all patients and sifts to lower wavenumbers.The ratio of the
bands of [Amide I1650]/[Amide II1550] decreases with increasing the grade of cancer and it was
found in the patients healthy bones to be equal to 1.11,whereas in the cancer it was 1.3.
Although the differences are very small they are significant and it was found also in breast
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cancer and colon cancer [18;21].These changes represent the “structural change and abnor‐
mality” of proteins, induced from cancer disease, which decrease the probability of re-
mineralization of the bones and thus increases the fragility of the bones.
Figure 1 clearly shows the absorption band at 1418 cm-1, which is assigned to stretching
vibration of carbonate anions (vCO32-) of hydroxyapatite containing carbonate ions. Thisband
is also reduced in intensity confirming the substitution of phosphate anions with carbonates
in hydroxyapatite following the total demineralization of cancerous bones [17,20].
The band at about 1040 cm-1 refers to stretching vibrations of vC-O coupled with the bending
vibration of δC-OH groups of glycogenic bonds [36,37]. We found that the intensity of this
band increases in the spectra of cancerous bones. The vOH absorption bands are sensitive upon
isotopic substitution (deuteration), concerning the substitution of hydrogen atoms with
deuterium in the C-OH groups of glucose (spectra not shown here). The increasing amount of
glycogenic materials inhibits the mineralization of the bones [38]. From the conformational
protein folding changes in combination with the increase glycogenic bonds (starch) it is
suggested the production of amyloid-like proteins [39]. The formation of fibrils is also well
shown in SEM morphology (Figure 2).
Furthermore, the spectra show characteristic differences between healthy and cancerous bone
in the regions 1200-900 cm-1and 600-500 cm-1, where the phosphate groups (v3PO43-) of hydrox‐
yapatite absorb. The characteristic bands of v3PO43-and v4PO43-in cancerous bones have been
dramatically decreased due to cancer, proving that osteolysis of the bones is taking place. These
findings show that in cancerous bone a progressive mineral deficiency occurs in agreement
with clinical and histological analyses indicating that the bone destruction is mediated by the
osteoclasts [40]. Moreover, in the fingerprint region of the cancerous spectra between 1200-900
cm-1 are coupled also the bands which are assigned to phosphodiester C-O-PO2-of DNA
[23-25,41-43]. These bands were not observed in normal bone tissue, maybe they were masked
because of high concentration of hydroxyapatite.
3.2. FT-IR spectra after removal of organic components
To understand further the mechanisms of osteolysis of bone from metastatic cancer the
boneswere washed using organic solvents to eliminate the organic mass of the bones. Figure
3 shows the spectra of the bone before (spectrum a) and after elimination of dissolved organic
components (spectrum b).
Comparison of the two spectra shows that after treatment with hexane all the organic com‐
ponents with low molecular weight have been dissolved and disappeared from the sample
and are not shown in their spectra. It is interesting to note that the bands in the region 1100-900
cm-1 and 700-500 cm-1, where the bands of hydroxyapatite absorb, the bands of vPO43-have
almost disappeared after treatment with hexane. From these findings it was suggested that the
bands haveresulted from other phosphate proteins, which also have phosphate groups with
hydroxyapatite or fragments of phospholipids. However, these bands do not show that there
is present biological hydroxyapatite. In addition, XRD analysis revealed that cancerous bones
were not consisted from biological hydroxyapatite, but there was apatite rich in organic phase.
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The size of the crystals at 2θ=25,85°was found to be 15 nm much smaller than the normal bone’s
hydroxyapatite which is 20-25 nm [44].
The SEM analysis of cancerous bones before treatment with hexane is given in Figure 4A. The
relative element concentration of the white spot and of the dark region, are shown in the Figure.
Figure 4. SEM-EDXmorphology and composition of metastatic breast cancerous bone before treatment: A; on white
spot and B; on black area. Scale 100 μm, Mag 400x
Figure 3. FT-IR spectra of cancerous bone tissues in the region 4000-400 cm-1; a: without any preparation, b: after elimi‐
nation of the organic components of the bone. The arrow shows free calcium phosphate.
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From EDX chemical analysis it was found that the extent area of the bone was poor in calcium
and only the spread white spots were rich in minerals. By washing the bone with hexane the
morphology of the surface changed (Figure 5). Figure 5 gives the SEM morphology of the bone
after washing it with hexane. Figure 5Agives the relative concentration of the chemical
elements of the white spots. It is obvious that the concentration of calcium of white spot is
significantly reduced. The same picture was found for the extent area of the sample, where the
calcium has almost disappeared (Figure 5B).
Figure 5. SEM-EDX results, composition of metastatic breast cancerous bone after treatment A; on white spot and B; on
balk area and C SEM morphology of the tissue. Scale 100 μm, Mag 400x
These SEM results are in agreement with infrared spectroscopic results, which suggest that
the mineral phase maybe a mixture of calcium salts of phosphate together with calcium
carbonate, but not a biological hydroxyapatite. It was found from XRD analysis at 2θ=25,85ο
that the crystal of hydroxya showed also that the size of the hydroxyapatite crystals is 15 nm.
This size is smaller than in healthy bones, which in adults was found 20-25 nm [44, 45].
4. Conclusions
The results obtained here using FT-IR spectroscopy and SEM analysis have shown that
cancerous bone from metastatic breast cancer leads to considerable changes in bone density,
especially in the structure of biological apatite that decreases dramatically or even it is
destroyed due to osteolysis.Proteins change their secondary structure from α-helix to random
coil and aldehydes are produced during cancer metabolism.The intensity of the aldehyde band
indicates the magnitude of the damage caused by the cancer. Furthermore, It is also noticed
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that the proportion of inorganic mass is reduced in comparison to the organic matrix upon
cancer invasion of the bones.
Furthermore, FT-IR spectroscopy can provide more information than histopathology, since it
does not need any decalcification for analysis. From a clinical point of view, major disadvan‐
tages of bone decalcification are the laborious procedure that proceeds only slowly with
incubation times up to several weeks depending on the extent of mineralization, the frequent
loss of immune-reactivity, and the acid hydrolysis of DNA. In addition, excessive decalcifica‐
tion may lead to negative or non-diagnostic biopsy of the bone specimen (Rey, 1991). In this
case, FT-IR spectroscopy is a rapid technique and it provides much more information com‐
pared to histology for a fast diagnosis of bone tumors.
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